Home » Topics » BioWorld Science

BioWorld Science
RSS

Ohara Pharmaceutical obtains certain rights to compound from PRISM Pharma

June 25, 2018

FDA awards orphan drug designation to PCS-499 for necrobiosis lipoidica

June 25, 2018

AZD-9567 shows better therapeutic ratio than prednisolone in vivo and in clinical setting

June 25, 2018

ARQ-531 demonstrates preliminary signs of antitumor activity in B-cell malignancies

June 25, 2018

Phase I results available for CUDC-907 in pediatric solid tumors

June 25, 2018

Lilly's acquisition of ARMO BioSciences complete

June 25, 2018

First-in-human data presented for oncolytic virus Celyvir in solid tumors

June 25, 2018

Biocad initiates phase I study of BCD-132 in patients with multiple sclerosis

June 25, 2018

iTeos Therapeutics completes series B financing to support immuno-oncology programs

June 25, 2018

Crinetics Pharmaceuticals awarded NIDDK grants

June 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...